595 related articles for article (PubMed ID: 11120869)
1. A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes.
Balasa B; La Cava A; Van Gunst K; Mocnik L; Balakrishna D; Nguyen N; Tucker L; Sarvetnick N
J Immunol; 2000 Dec; 165(12):7330-7. PubMed ID: 11120869
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
3. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
[TBL] [Abstract][Full Text] [Related]
4. IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse.
Balasa B; Van Gunst K; Jung N; Katz JD; Sarvetnick N
Cell Immunol; 2000 Jun; 202(2):97-102. PubMed ID: 10896769
[TBL] [Abstract][Full Text] [Related]
5. Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules.
Balasa B; Van Gunst K; Jung N; Balakrishna D; Santamaria P; Hanafusa T; Itoh N; Sarvetnick N
J Immunol; 2000 Sep; 165(5):2841-9. PubMed ID: 10946317
[TBL] [Abstract][Full Text] [Related]
6. Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice.
Judkowski V; Pinilla C; Schroder K; Tucker L; Sarvetnick N; Wilson DB
J Immunol; 2001 Jan; 166(2):908-17. PubMed ID: 11145667
[TBL] [Abstract][Full Text] [Related]
7. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice.
Kanagawa O; Militech A; Vaupel BA
J Immunol; 2002 Jun; 168(12):6159-64. PubMed ID: 12055228
[TBL] [Abstract][Full Text] [Related]
8. A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice.
Tisch R; Wang B; Atkinson MA; Serreze DV; Friedline R
J Immunol; 2001 Jun; 166(11):6925-36. PubMed ID: 11359854
[TBL] [Abstract][Full Text] [Related]
9. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.
Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA
J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883
[TBL] [Abstract][Full Text] [Related]
10. The activity of immunoregulatory T cells mediating active tolerance is potentiated in nonobese diabetic mice by an IL-4-based retroviral gene therapy.
Yamamoto AM; Chernajovsky Y; Lepault F; Podhajcer O; Feldmann M; Bach JF; Chatenoud L
J Immunol; 2001 Apr; 166(8):4973-80. PubMed ID: 11290776
[TBL] [Abstract][Full Text] [Related]
11. Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice.
Balasa B; Lee J; Sarvetnick N
Cell Immunol; 1999 May; 193(2):170-8. PubMed ID: 10222059
[TBL] [Abstract][Full Text] [Related]
12. H-2D end confers dominant protection from IL-10-mediated acceleration of autoimmune diabetes in the nonobese diabetic mouse.
La Cava A; Balasa B; Good A; van Gunst K; Jung N; Sarvetnick N
J Immunol; 2001 Jul; 167(2):1066-71. PubMed ID: 11441117
[TBL] [Abstract][Full Text] [Related]
13. Presence of diabetes-inhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic mice.
You S; Chen C; Lee WH; Brusko T; Atkinson M; Liu CP
J Immunol; 2004 Dec; 173(11):6777-85. PubMed ID: 15557171
[TBL] [Abstract][Full Text] [Related]
14. Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.
Kim SK; Tarbell KV; Sanna M; Vadeboncoeur M; Warganich T; Lee M; Davis M; McDevitt HO
Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14204-9. PubMed ID: 15381770
[TBL] [Abstract][Full Text] [Related]
15. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
[TBL] [Abstract][Full Text] [Related]
16. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
[TBL] [Abstract][Full Text] [Related]
17. Expression of intercellular adhesion molecule 1 on pancreatic beta-cells accelerates beta-cell destruction by cytotoxic T-cells in murine autoimmune diabetes.
Yagi N; Yokono K; Amano K; Nagata M; Tsukamoto K; Hasegawa Y; Yoneda R; Okamoto N; Moriyama H; Miki M
Diabetes; 1995 Jul; 44(7):744-52. PubMed ID: 7789642
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
Hussain S; Delovitch TL
J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
[TBL] [Abstract][Full Text] [Related]
19. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells.
Yoon JW; Yoon CS; Lim HW; Huang QQ; Kang Y; Pyun KH; Hirasawa K; Sherwin RS; Jun HS
Science; 1999 May; 284(5417):1183-7. PubMed ID: 10325232
[TBL] [Abstract][Full Text] [Related]
20. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen.
Laloux V; Beaudoin L; Jeske D; Carnaud C; Lehuen A
J Immunol; 2001 Mar; 166(6):3749-56. PubMed ID: 11238616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]